ReP USP - Resultado da busca

Artigo de periodico
Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy (2020)
Marcatto, Leiliane Rodrigues; Sacilotto, Luciana; Tavares, Leticia Camargo; Souza, Debora Stephanie Pereira; Olivetti, Natalia Quintella Sangiorgi ; Strunz, Celia Maria Cassaro; Darrieux, Francisco Carlos Costa; Scanavacca, Mauricio Ibrahim; Krieger, Jose Eduardo ; Pereira, Alexandre Costa
Source: Frontiers in pharmacology. Unidade: FM
Subjects: ANTICOAGULANTES, SERVIÇOS FARMACÊUTICOS, TEMPO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCATTO, Leiliane Rodrigues et al. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy. Frontiers in pharmacology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.01056. Acesso em: 19 nov. 2024.
APA
Marcatto, L. R., Sacilotto, L., Tavares, L. C., Souza, D. S. P., Olivetti, N. Q. S., Strunz, C. M. C., et al. (2020). Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy. Frontiers in pharmacology, 11. doi:10.3389/fphar.2020.01056
NLM
Marcatto LR, Sacilotto L, Tavares LC, Souza DSP, Olivetti NQS, Strunz CMC, Darrieux FCC, Scanavacca MI, Krieger JE, Pereira AC. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fphar.2020.01056
Vancouver
Marcatto LR, Sacilotto L, Tavares LC, Souza DSP, Olivetti NQS, Strunz CMC, Darrieux FCC, Scanavacca MI, Krieger JE, Pereira AC. Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fphar.2020.01056
Artigo de periodico
Pharmaceutical care Increases time in therapeutic range of patients with poor quality of anticoagulation with warfarin (2018)
Marcatto, Leiliane Rodrigues; Krieger, Jose Eduardo
Source: Frontiers in pharmacology. Unidade: FM
Subjects: ANTICOAGULANTES, TROMBOSE, TERAPÊUTICA MÉDICA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARCATTO, Leiliane Rodrigues e KRIEGER, Jose Eduardo. Pharmaceutical care Increases time in therapeutic range of patients with poor quality of anticoagulation with warfarin. Frontiers in pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.01052. Acesso em: 19 nov. 2024.
APA
Marcatto, L. R., & Krieger, J. E. (2018). Pharmaceutical care Increases time in therapeutic range of patients with poor quality of anticoagulation with warfarin. Frontiers in pharmacology, 9. doi:10.3389/fphar.2018.01052
NLM
Marcatto LR, Krieger JE. Pharmaceutical care Increases time in therapeutic range of patients with poor quality of anticoagulation with warfarin [Internet]. Frontiers in pharmacology. 2018 ; 9[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fphar.2018.01052
Vancouver
Marcatto LR, Krieger JE. Pharmaceutical care Increases time in therapeutic range of patients with poor quality of anticoagulation with warfarin [Internet]. Frontiers in pharmacology. 2018 ; 9[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fphar.2018.01052
Artigo de periodico
Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population (2018)
Tavares, Leticia C.; Duarte, Nubia E; Marcatto, Leiliane R; Soares, Renata A. G; Krieger, José Eduardo; Pereira, Alexandre C; Santos, Paulo Caleb Junior Lima
Source: European journal of clinical pharmacology. Unidade: FM
Subjects: POLIMORFISMO, ANTICOAGULANTES, ALGORITMOS GENÉTICOS, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Leticia C. et al. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European journal of clinical pharmacology, v. 74, n. 12, p. 1555-1566, 2018Tradução . . Disponível em: https://doi.org/10.1007/s00228-018-2528-z. Acesso em: 19 nov. 2024.
APA
Tavares, L. C., Duarte, N. E., Marcatto, L. R., Soares, R. A. G., Krieger, J. E., Pereira, A. C., & Santos, P. C. J. L. (2018). Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population. European journal of clinical pharmacology, 74( 12), 1555-1566. doi:10.1007/s00228-018-2528-z
NLM
Tavares LC, Duarte NE, Marcatto LR, Soares RAG, Krieger JE, Pereira AC, Santos PCJL. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population [Internet]. European journal of clinical pharmacology. 2018 ; 74( 12): 1555-1566.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s00228-018-2528-z
Vancouver
Tavares LC, Duarte NE, Marcatto LR, Soares RAG, Krieger JE, Pereira AC, Santos PCJL. Impact of incorporating ABCB1 and CYP4F2 polymorphisms in a pharmacogenetics-guided warfarin dosing algorithm for the Brazilian population [Internet]. European journal of clinical pharmacology. 2018 ; 74( 12): 1555-1566.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s00228-018-2528-z
Artigo de periodico
Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients (2018)
Tavares, Leticia C.; Krieger, Jose E.
Source: Frontiers in pharmacology. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, BRASILEIROS, POLIMORFISMO, ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAVARES, Leticia C. e KRIEGER, Jose E. Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients. Frontiers in pharmacology, v. 9, 2018Tradução . . Disponível em: https://doi.org/10.3389/fphar.2018.00542. Acesso em: 19 nov. 2024.
APA
Tavares, L. C., & Krieger, J. E. (2018). Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients. Frontiers in pharmacology, 9. doi:10.3389/fphar.2018.00542
NLM
Tavares LC, Krieger JE. Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients [Internet]. Frontiers in pharmacology. 2018 ; 9[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fphar.2018.00542
Vancouver
Tavares LC, Krieger JE. Association Between ABCB1 Polymorphism and Stable Warfarin Dose Requirements in Brazilian Patients [Internet]. Frontiers in pharmacology. 2018 ; 9[citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/fphar.2018.00542
Artigo de periodico
Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration (2015)
Santos, Paulo Caleb Junior Lima; Marcatto, Leiliane Rodrigues; Duarte, Nubia Esteban; Soares, Renata Alonso Gadi; Strunz, Celia Maria Cassaro; Scanavacca, Maurício; Krieger, Jose Eduardo; Pereira, Alexandre Costa
Source: Pharmacogenomics. Unidade: FM
Subjects: TROMBOSE, BRASILEIROS, ALGORITMOS ÚTEIS E ESPECÍFICOS, FARMACOGENÉTICA (TENDÊNCIAS), ANTICOAGULANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTOS, Paulo Caleb Junior Lima et al. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration. Pharmacogenomics, v. 16, n. 8, p. 865-876, 2015Tradução . . Disponível em: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.15.48. Acesso em: 19 nov. 2024.
APA
Santos, P. C. J. L., Marcatto, L. R., Duarte, N. E., Soares, R. A. G., Strunz, C. M. C., Scanavacca, M., et al. (2015). Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration. Pharmacogenomics, 16( 8), 865-876. doi:10.2217/PGS.15.48
NLM
Santos PCJL, Marcatto LR, Duarte NE, Soares RAG, Strunz CMC, Scanavacca M, Krieger JE, Pereira AC. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration [Internet]. Pharmacogenomics. 2015 ; 16( 8): 865-876.[citado 2024 nov. 19 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.15.48
Vancouver
Santos PCJL, Marcatto LR, Duarte NE, Soares RAG, Strunz CMC, Scanavacca M, Krieger JE, Pereira AC. Development of a pharmacogenetic-based warfarin dosing algorithm and its performance in Brazilian patients: highlighting the importance of population-specific calibration [Internet]. Pharmacogenomics. 2015 ; 16( 8): 865-876.[citado 2024 nov. 19 ] Available from: http://www.futuremedicine.com/doi/pdf/10.2217/pgs.15.48

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em